nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—DDR1—uterine cervix—vaginal cancer	0.023	0.023	CbGeAlD
Imatinib—ABCA3—urethra—vaginal cancer	0.0229	0.0229	CbGeAlD
Imatinib—ABCA3—endometrium—vaginal cancer	0.0226	0.0226	CbGeAlD
Imatinib—ABCA3—mammalian vulva—vaginal cancer	0.0218	0.0218	CbGeAlD
Imatinib—DDR1—urethra—vaginal cancer	0.0212	0.0212	CbGeAlD
Imatinib—DDR1—endometrium—vaginal cancer	0.0208	0.0208	CbGeAlD
Imatinib—DDR1—mammalian vulva—vaginal cancer	0.0202	0.0202	CbGeAlD
Imatinib—DDR1—uterus—vaginal cancer	0.0192	0.0192	CbGeAlD
Imatinib—HIPK4—female reproductive system—vaginal cancer	0.0189	0.0189	CbGeAlD
Imatinib—ABCA3—female gonad—vaginal cancer	0.017	0.017	CbGeAlD
Imatinib—ABCA3—vagina—vaginal cancer	0.0169	0.0169	CbGeAlD
Imatinib—DDR1—female gonad—vaginal cancer	0.0157	0.0157	CbGeAlD
Imatinib—DDR1—vagina—vaginal cancer	0.0156	0.0156	CbGeAlD
Imatinib—PIP4K2C—uterine cervix—vaginal cancer	0.0142	0.0142	CbGeAlD
Imatinib—CA3—uterine cervix—vaginal cancer	0.0136	0.0136	CbGeAlD
Imatinib—PIP4K2C—urethra—vaginal cancer	0.0131	0.0131	CbGeAlD
Imatinib—PIP4K2C—endometrium—vaginal cancer	0.0129	0.0129	CbGeAlD
Imatinib—LCK—uterine cervix—vaginal cancer	0.0126	0.0126	CbGeAlD
Imatinib—PIP4K2C—mammalian vulva—vaginal cancer	0.0124	0.0124	CbGeAlD
Imatinib—LCK—urethra—vaginal cancer	0.0116	0.0116	CbGeAlD
Imatinib—CA3—uterus—vaginal cancer	0.0113	0.0113	CbGeAlD
Imatinib—LCK—mammalian vulva—vaginal cancer	0.011	0.011	CbGeAlD
Imatinib—PIP4K2C—female reproductive system—vaginal cancer	0.0107	0.0107	CbGeAlD
Imatinib—LCK—uterus—vaginal cancer	0.0105	0.0105	CbGeAlD
Imatinib—NQO2—uterine cervix—vaginal cancer	0.0104	0.0104	CbGeAlD
Imatinib—ABL2—female gonad—vaginal cancer	0.0102	0.0102	CbGeAlD
Imatinib—ABL2—vagina—vaginal cancer	0.0102	0.0102	CbGeAlD
Imatinib—CA9—female reproductive system—vaginal cancer	0.00974	0.00974	CbGeAlD
Imatinib—PIP4K2C—female gonad—vaginal cancer	0.0097	0.0097	CbGeAlD
Imatinib—PIP4K2C—vagina—vaginal cancer	0.00964	0.00964	CbGeAlD
Imatinib—NQO2—urethra—vaginal cancer	0.0096	0.0096	CbGeAlD
Imatinib—NQO2—endometrium—vaginal cancer	0.00945	0.00945	CbGeAlD
Imatinib—CA3—vagina—vaginal cancer	0.0092	0.0092	CbGeAlD
Imatinib—CSF1R—uterine cervix—vaginal cancer	0.00917	0.00917	CbGeAlD
Imatinib—NQO2—mammalian vulva—vaginal cancer	0.00914	0.00914	CbGeAlD
Imatinib—NQO2—uterus—vaginal cancer	0.00871	0.00871	CbGeAlD
Imatinib—PDGFRA—uterus—vaginal cancer	0.00868	0.00868	CbGeAlD
Imatinib—LCK—female gonad—vaginal cancer	0.00861	0.00861	CbGeAlD
Imatinib—LCK—vagina—vaginal cancer	0.00855	0.00855	CbGeAlD
Imatinib—CSF1R—urethra—vaginal cancer	0.00843	0.00843	CbGeAlD
Imatinib—KIT—epithelium—vaginal cancer	0.0084	0.0084	CbGeAlD
Imatinib—SLC47A1—uterine cervix—vaginal cancer	0.00838	0.00838	CbGeAlD
Imatinib—KIT—uterine cervix—vaginal cancer	0.00833	0.00833	CbGeAlD
Imatinib—CSF1R—endometrium—vaginal cancer	0.0083	0.0083	CbGeAlD
Imatinib—PDGFRB—epithelium—vaginal cancer	0.00821	0.00821	CbGeAlD
Imatinib—PDGFRB—uterine cervix—vaginal cancer	0.00814	0.00814	CbGeAlD
Imatinib—CSF1R—mammalian vulva—vaginal cancer	0.00803	0.00803	CbGeAlD
Imatinib—NQO2—female reproductive system—vaginal cancer	0.00783	0.00783	CbGeAlD
Imatinib—PDGFRA—female reproductive system—vaginal cancer	0.00781	0.00781	CbGeAlD
Imatinib—SLC47A1—urethra—vaginal cancer	0.0077	0.0077	CbGeAlD
Imatinib—KIT—urethra—vaginal cancer	0.00765	0.00765	CbGeAlD
Imatinib—CSF1R—uterus—vaginal cancer	0.00765	0.00765	CbGeAlD
Imatinib—SLC47A1—endometrium—vaginal cancer	0.00758	0.00758	CbGeAlD
Imatinib—KIT—endometrium—vaginal cancer	0.00753	0.00753	CbGeAlD
Imatinib—PDGFRB—urethra—vaginal cancer	0.00748	0.00748	CbGeAlD
Imatinib—PDGFRB—endometrium—vaginal cancer	0.00736	0.00736	CbGeAlD
Imatinib—SLC47A1—mammalian vulva—vaginal cancer	0.00733	0.00733	CbGeAlD
Imatinib—KIT—mammalian vulva—vaginal cancer	0.00729	0.00729	CbGeAlD
Imatinib—ABL1—uterine cervix—vaginal cancer	0.00725	0.00725	CbGeAlD
Imatinib—CA12—female reproductive system—vaginal cancer	0.00721	0.00721	CbGeAlD
Imatinib—NQO2—female gonad—vaginal cancer	0.00712	0.00712	CbGeAlD
Imatinib—PDGFRB—mammalian vulva—vaginal cancer	0.00712	0.00712	CbGeAlD
Imatinib—PDGFRA—female gonad—vaginal cancer	0.0071	0.0071	CbGeAlD
Imatinib—NQO2—vagina—vaginal cancer	0.00708	0.00708	CbGeAlD
Imatinib—PDGFRA—vagina—vaginal cancer	0.00706	0.00706	CbGeAlD
Imatinib—SLC47A1—uterus—vaginal cancer	0.00698	0.00698	CbGeAlD
Imatinib—KIT—uterus—vaginal cancer	0.00694	0.00694	CbGeAlD
Imatinib—ORM1—endometrium—vaginal cancer	0.0069	0.0069	CbGeAlD
Imatinib—CSF1R—female reproductive system—vaginal cancer	0.00687	0.00687	CbGeAlD
Imatinib—PDGFRB—uterus—vaginal cancer	0.00678	0.00678	CbGeAlD
Imatinib—ABL1—urethra—vaginal cancer	0.00666	0.00666	CbGeAlD
Imatinib—ABL1—endometrium—vaginal cancer	0.00656	0.00656	CbGeAlD
Imatinib—ABL1—mammalian vulva—vaginal cancer	0.00634	0.00634	CbGeAlD
Imatinib—SLC47A1—female reproductive system—vaginal cancer	0.00628	0.00628	CbGeAlD
Imatinib—CSF1R—female gonad—vaginal cancer	0.00625	0.00625	CbGeAlD
Imatinib—KIT—female reproductive system—vaginal cancer	0.00624	0.00624	CbGeAlD
Imatinib—CSF1R—vagina—vaginal cancer	0.00622	0.00622	CbGeAlD
Imatinib—PDGFRB—female reproductive system—vaginal cancer	0.0061	0.0061	CbGeAlD
Imatinib—ABL1—uterus—vaginal cancer	0.00604	0.00604	CbGeAlD
Imatinib—ORM1—female reproductive system—vaginal cancer	0.00572	0.00572	CbGeAlD
Imatinib—SLC47A1—female gonad—vaginal cancer	0.00571	0.00571	CbGeAlD
Imatinib—CA1—female reproductive system—vaginal cancer	0.00571	0.00571	CbGeAlD
Imatinib—KIT—female gonad—vaginal cancer	0.00568	0.00568	CbGeAlD
Imatinib—SLC47A1—vagina—vaginal cancer	0.00568	0.00568	CbGeAlD
Imatinib—KIT—vagina—vaginal cancer	0.00564	0.00564	CbGeAlD
Imatinib—PDGFRB—female gonad—vaginal cancer	0.00555	0.00555	CbGeAlD
Imatinib—PDGFRB—vagina—vaginal cancer	0.00551	0.00551	CbGeAlD
Imatinib—ABL1—female reproductive system—vaginal cancer	0.00543	0.00543	CbGeAlD
Imatinib—CA2—epithelium—vaginal cancer	0.00498	0.00498	CbGeAlD
Imatinib—ABL1—female gonad—vaginal cancer	0.00494	0.00494	CbGeAlD
Imatinib—ABL1—vagina—vaginal cancer	0.00491	0.00491	CbGeAlD
Imatinib—SLC22A1—vagina—vaginal cancer	0.00474	0.00474	CbGeAlD
Imatinib—ABCG2—uterine cervix—vaginal cancer	0.00457	0.00457	CbGeAlD
Imatinib—CA2—mammalian vulva—vaginal cancer	0.00432	0.00432	CbGeAlD
Imatinib—CYP3A5—uterine cervix—vaginal cancer	0.00424	0.00424	CbGeAlD
Imatinib—ABCG2—urethra—vaginal cancer	0.0042	0.0042	CbGeAlD
Imatinib—ABCG2—endometrium—vaginal cancer	0.00414	0.00414	CbGeAlD
Imatinib—ABCG2—mammalian vulva—vaginal cancer	0.004	0.004	CbGeAlD
Imatinib—PTGS1—epithelium—vaginal cancer	0.00385	0.00385	CbGeAlD
Imatinib—PTGS1—uterine cervix—vaginal cancer	0.00381	0.00381	CbGeAlD
Imatinib—ABCG2—uterus—vaginal cancer	0.00381	0.00381	CbGeAlD
Imatinib—CA2—female reproductive system—vaginal cancer	0.0037	0.0037	CbGeAlD
Imatinib—CYP2C19—vagina—vaginal cancer	0.00365	0.00365	CbGeAlD
Imatinib—PTGS1—endometrium—vaginal cancer	0.00345	0.00345	CbGeAlD
Imatinib—CA2—female gonad—vaginal cancer	0.00337	0.00337	CbGeAlD
Imatinib—CA2—vagina—vaginal cancer	0.00335	0.00335	CbGeAlD
Imatinib—PTGS1—mammalian vulva—vaginal cancer	0.00334	0.00334	CbGeAlD
Imatinib—PTGS1—uterus—vaginal cancer	0.00318	0.00318	CbGeAlD
Imatinib—CYP2C9—female reproductive system—vaginal cancer	0.00313	0.00313	CbGeAlD
Imatinib—ABCG2—female gonad—vaginal cancer	0.00312	0.00312	CbGeAlD
Imatinib—ABCG2—vagina—vaginal cancer	0.0031	0.0031	CbGeAlD
Imatinib—CYP3A5—female gonad—vaginal cancer	0.00289	0.00289	CbGeAlD
Imatinib—CYP3A5—vagina—vaginal cancer	0.00288	0.00288	CbGeAlD
Imatinib—PTGS1—female reproductive system—vaginal cancer	0.00286	0.00286	CbGeAlD
Imatinib—PTGS1—female gonad—vaginal cancer	0.0026	0.0026	CbGeAlD
Imatinib—PTGS1—vagina—vaginal cancer	0.00258	0.00258	CbGeAlD
Imatinib—CYP3A4—female reproductive system—vaginal cancer	0.00239	0.00239	CbGeAlD
Imatinib—CYP2D6—female reproductive system—vaginal cancer	0.00235	0.00235	CbGeAlD
Imatinib—ABCB1—epithelium—vaginal cancer	0.00227	0.00227	CbGeAlD
Imatinib—ABCB1—uterine cervix—vaginal cancer	0.00225	0.00225	CbGeAlD
Imatinib—CYP2D6—female gonad—vaginal cancer	0.00214	0.00214	CbGeAlD
Imatinib—ABCB1—urethra—vaginal cancer	0.00207	0.00207	CbGeAlD
Imatinib—ABCB1—endometrium—vaginal cancer	0.00204	0.00204	CbGeAlD
Imatinib—ABCB1—mammalian vulva—vaginal cancer	0.00197	0.00197	CbGeAlD
Imatinib—ABCB1—uterus—vaginal cancer	0.00188	0.00188	CbGeAlD
Imatinib—ABCB1—female reproductive system—vaginal cancer	0.00169	0.00169	CbGeAlD
Imatinib—ABCB1—female gonad—vaginal cancer	0.00154	0.00154	CbGeAlD
Imatinib—ABCB1—vagina—vaginal cancer	0.00153	0.00153	CbGeAlD
